BioVectra has made significant investment in containment and is a leading CDMO in the development and cGMP scale-up of small high potency APIs. Our fermentation and chemical processing suites are equipped to handle potent substances with occupational exposure limit (OEL) levels of < 20 ng/m3 (Safebridge Band 3 and 4). Our facilities were designed in consultation with pharmaceutical clients and have been audited for EH&S compliance.
We provide comprehensive potent handling training to our scientists and manufacturing staff and perform extensive environmental monitoring, including industrial hygiene methods.
OEL levels of < 20 ng/m3
Please contact us to learn more about our high potency API capabilities.